We are live on
!
Find out more
CBU
CIBC Bancorp USA Portfolio holdings
AUM
$82.3B
This Fund
S&P 500
This Quarter
Est. Return
-2.4%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$74.4B
AUM Growth
–
Cap. Flow
+$77.6B
Cap. Flow
% of AUM
104.34%
Top 10 Holdings %
Top 10 Hldgs %
28.33%
Holding
1,750
New
1,740
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.17B |
| 2 |
Microsoft
MSFT
|
+$3.62B |
| 3 |
Apple
AAPL
|
+$3.55B |
| 4 |
Amazon
AMZN
|
+$2.58B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$2.51B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.75% |
| 2 | Miscellaneous | 12.61% |
| 3 | Financials | 10.83% |
| 4 | Healthcare | 10.2% |
| 5 | Consumer Discretionary | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
indie Semiconductor
INDI
$686M
| $32.5K | ﹤0.01% |
+10,098
| New | +$35.7K |
|
1727
Gevo
GEVO
$329M
| $32.2K | ﹤0.01% |
+11,784
| New | +$24.4K |
|
1728
Vuzix
VUZI
$234M
| $31.1K | ﹤0.01% |
+13,442
| New | +$36.7K |
|
1729
Editas Medicine
EDIT
$398M
| $30.3K | ﹤0.01% |
+12,255
| New | +$25.9K |
|
|
RZLV
1730
Rezolve AI
RZLV
$884M
| $28.6K | ﹤0.01% |
+11,182
| New | +$31.5K |
|
1731
Sabre
SABR
$860M
| $27.4K | ﹤0.01% |
+18,914
| New | +$25.2K |
|
1732
Richtech Robotics
RR
$358M
| $26.9K | ﹤0.01% |
+12,878
| New | +$39.6K |
|
1733
AMC Entertainment Holdings
AMC
$2.75B
| $25.7K | ﹤0.01% |
+26,233
| New | +$33.8K |
|
1734
ProShares UltraPro QQQ
TQQQ
$37.7B
| $25.1K | ﹤0.01% |
+10,602
| New | +$530K |
|
1735
Opko Health
OPK
$1.21B
| $23.6K | ﹤0.01% |
+20,721
| New | +$25.5K |
|
1736
Bit Digital
BTBT
$595M
| $23K | ﹤0.01% |
+17,533
| New | +$32.2K |
|
1737
Aldeyra Therapeutics
ALDX
$79.6M
| $22.4K | ﹤0.01% |
+13,237
| New | +$58K |
|
|
IPST
1738
IP Strategy Holdings
IPST
$2.19M
| $21.1K | ﹤0.01% |
+4,000
| New | +$73.6K |
|
1739
CXApp
CXAI
$5.91M
| $19.5K | ﹤0.01% |
+2,160
| New | +$26.9K |
|
1740
Pacific Biosciences
PACB
$569M
| $19.2K | ﹤0.01% |
+14,514
| New | +$26K |
|
1741
Akebia Therapeutics
AKBA
$246M
| $17.7K | ﹤0.01% |
+12,750
| New | +$17.5K |
|
|
OPTU
1742
Optimum Communications Inc
OPTU
$389M
| $17.1K | ﹤0.01% |
+13,164
| New | +$20.7K |
|
|
NXDR
1743
Nextdoor Holdings
NXDR
$948M
| $15.7K | ﹤0.01% |
+11,200
| New | +$19.5K |
|
1744
Beyond Meat
BYND
$142M
| $15.3K | ﹤0.01% |
+728
| New | +$17.5K |
|
1745
Microvast
MVST
$249M
| $15K | ﹤0.01% |
+10,026
| New | +$24.1K |
|
1746
Standard BioTools
LAB
$280M
| $14.6K | ﹤0.01% |
+15,877
| New | +$19.2K |
|
1747
Alight
ALIT
$261M
| $13.6K | ﹤0.01% |
+1,170
| New | +$27.9K |
|
1748
Heartbeam
BEAT
$20.7M
| $13K | ﹤0.01% |
+10,631
| New | +$17K |
|
1749
Microvision
MVIS
$44.7M
| $9.87K | ﹤0.01% |
+1,027
| New | +$11.8K |
|
|
FSP
1750
Franklin Street Properties
FSP
$37.4M
| $7.96K | ﹤0.01% |
+11,972
| New | +$9.26K |
|
Similar funds
QCM
CIBC Bancorp USA's Q1 2026 Portfolio in Review
As of Q1 2026, CIBC Bancorp USA held 1,750 positions worth $74.4B. Its ten largest holdings account for 28% of the portfolio.
CIBC Bancorp USA deployed $77.6B of net new capital in Q1 2026, opening 1,740 new positions. Its largest new stake was NVIDIA: 22,706,796 shares worth $3.96B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, followed by Miscellaneous and Financials.
- CIBC Bancorp USA's largest Q1 2026 buy was NVIDIA: 22,706,796 shares worth $3.96B.
- CIBC Bancorp USA's ten largest holdings make up 28% of its $74.4B portfolio in Q1 2026.
- CIBC Bancorp USA opened 1,740 new positions and closed 0 in Q1 2026.
Based on CIBC Bancorp USA's 13F filing for Q1 2026, filed 12 May 2026.